Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Antihemophilic Factor, Human Recombinant 1 UNT Injection [Advate]

Known as: Advate 1 UNT Injection, ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT 50 [iU] in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ADVATE], ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT 800 [iU] in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ADVATE] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Accurate determination of coagulation factor VIII activity (FVIII:C) is essential for effective and safe FVIII replacement… Expand
2018
2018
Rurioctocog alfa (recombinant factor VIII: Advate®) is available for the control of bleeding among patients with hemophilia A in… Expand
  • table 1
  • table 2
  • table 3
  • table 4
2012
2012
Summary We report a prospective trial of 55 previously untreated patients (PUPs) and minimally treated patients (MTPs) with… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
2012
2012
Prophylaxis or on-demand therapy with octocog alfa, antihemophilic factor, plasma/albumin-free method (Advate®) is effective for… Expand
  • table I
  • table II
  • table III
  • table IV
2011
2011
Abstract 4346 The pharmacokinetic profile of BAX 855, a longer acting PEGylated variant of Baxter’s recombinant FVIII based on… Expand
2011
2011
  • M. Łętowska, wybranych zagadnień, Nowe rekombinowane białka
  • 2011
  • Corpus ID: 62860136
Nowe rekombinowane białka Rekombinowany czynnik VIII Powell i wsp. przedstawili wyniki otwartego, wieloośrodkowego badania z… Expand
2010
2010
Summary.  The aim of this study was to evaluate the in vitro function of the new recombinant factor VIII (FVIII) compound, N8… Expand
2009
2009
Background:  Xyntha® (albumin-free cell culture process) is a BDDrFVIII manufactured using an albumin-free cell culture process… Expand
2005
2005
AbstractObjectives: To the extent that current recombinant clotting factor concentrates contain even trace amounts of human or… Expand
2004
2004
Initial data on safety and efficacy of new therapeutic agents are provided by formal clinical research studies. These provide… Expand